Liver Injury Following Intravenous Methylprednisolone Pulse Therapy in Multiple Sclerosis: The Experience from a Single Academic Liver Center
Biomolecules · 2025
DOI: 10.3390/biom15030437 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Dimitris Kounatidis und 11 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Hippokration General Hospital, 11527 Athens, …. Hauptthemen laut MEDLINE: Methylprednisolone, Multiple Sclerosis, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intravenous methylprednisolone (IVMP) pulses, widely used for managing multiple sclerosis (MS) exacerbations, can lead to acute liver injury, presenting a diagnostic challenge in distinguishing between drug-induced autoimmune-like hepatitis (DI-ALH) and idiopathic autoimmune hepatitis (AIH). This study aimed to delineate the clinical and biochemical features of IVMP-induced liver injury, discern its etiology, and evaluate the efficacy of glucocorticoid (GC) therapy in treatment. A retrospective analysis of 13 relapsing MS patients with IVMP-induced liver injury was conducted. Liver injury was classified as hepatocellular, cholestatic, or mixed, with severity assessment guiding liver biopsy in selected cases. Causality was assessed using the Roussel Uclaf Causality Assessment Method (RUCAM) and the Simplified Diagnostic Criteria for AIH. All patients were initially monitored for a minimum of six months, with a mean follow-up period of 4.30 years. The median onset of liver injury was 37.46 days post-IVMP, with a mean peak alanine transaminase (ALT) level of 618.46 U/L. antinuclear antibody (ANA) positivity was observed in 61.53% of cases, with elevated serum immunoglobulin G (IgG) at 15.38%. Hepatocellular injury was universal among patients, and causality assessment predominantly supported DI-ALH. GC therapy was administered in six cases, achieving favorable outcomes in all but one, which necessitated rituximab. Biochemical normalization occurred within a mean of 55.41 days, with GC-treated patients recovering faster (48 days). These findings support the hypothesis that IVMP can induce hepatocellular injury, likely DI-ALH, during MS exacerbations. A tapering GC regimen proved effective in promoting recovery, particularly in severe cases. Additionally, this study introduced a diagnostic and therapeutic algorithm for managing IVMP-induced liver injury, offering a practical framework for clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Second Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Hippokration General Hospital, 11527 Athens, Greece.
- Diabetes Center, First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, 11527 Athens, Greece.
- First Department of Internal Medicine, Sismanogleio General Hospital, 15126 Athens, Greece.
- Second Department of Internal Medicine, 401 General Army Hospital of Athens, 15561 Athens, Greece.
- Rheumatology Unit, First Department of Propaedeutic Internal Medicine, Joint Academic Rheumatology Program, Medical School, National & Kapodistrian University of Athens, Laiko General Hospital, 11527 Athens, Greece.
ORCID-Profile: Dimitris Kounatidis, Natalia G Vallianou, Hariklia Kranidioti, Nikolaos Papadopoulos, Vasileios Papadimitropoulos, Melanie Deutsch
Zitieren
APA
Kounatidis, D., Vallianou, N. G., Kontos, G., Kranidioti, H., Papadopoulos, N., Panagiotopoulos, A., Dimitriou, K., Papadimitropoulos, V., Deutsch, M., Manolakopoulos, S., Vassilopoulos, D., & Koskinas, J. (2025). Liver Injury Following Intravenous Methylprednisolone Pulse Therapy in Multiple Sclerosis: The Experience from a Single Academic Liver Center. Biomolecules. https://doi.org/10.3390/biom15030437
Vancouver
Kounatidis D, Vallianou NG, Kontos G, Kranidioti H, Papadopoulos N, Panagiotopoulos A, et al. Liver Injury Following Intravenous Methylprednisolone Pulse Therapy in Multiple Sclerosis: The Experience from a Single Academic Liver Center. Biomolecules. 2025. doi:10.3390/biom15030437
BibTeX
@article{Kounatidis2025,
author = {Kounatidis, Dimitris and Vallianou, Natalia G and Kontos, Georgios and Kranidioti, Hariklia and Papadopoulos, Nikolaos and Panagiotopoulos, Alexandros and Dimitriou, Krystalia and Papadimitropoulos, Vasileios and Deutsch, Melanie and Manolakopoulos, Spilios and Vassilopoulos, Dimitrios and Koskinas, John},
title = {Liver Injury Following Intravenous Methylprednisolone Pulse Therapy in Multiple Sclerosis: The Experience from a Single Academic Liver Center},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15030437}
}
EUVIMED